Black Diamond Therapeutics remains undervalued despite recent share price gains, with a promising EGFR inhibitor pipeline ...

Cancer-fighting antibody drugs are designed to penetrate tumor cells and release a lethal payload deep within, but too often ...

Adults with prediabetes experience a faster decline in kidney function than those with normal glucose, highlighting the need ...

Acoramidis significantly reduced all-cause mortality in both wild-type and variant amyloid cardiomyopathy through 42 months of the ATTRibute-CM study. The study demonstrated consistent efficacy in ...

Study findings debunk the theory that lupus nephritis is more severe with worse outcomes in men vs women. Men and women with lupus nephritis exhibit similar disease severity, therapeutic responses, ...

Janux Therapeutics' cash runway is about 12 months; dilution is likely, and upcoming data from both JANX007 and JANX008 are ...

Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now discovered a molecular-level resistance mechanism that begins to take hold as ...

The Food and Drug Administration (FDA) has granted accelerated approval to Voyxact ® (sibeprenlimab-szsi) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for ...

Kidney disease affects millions globally and often progresses silently. Experts recommend four simple screening tests for ...